Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Chemocentryx Inc (NQ: CCXI ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Oct 19, 2022 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Chemocentryx Inc < Previous 1 2 3 4 5 6 7 8 9 Next > 12 Health Care Stocks Moving In Thursday's Intraday Session August 04, 2022 Via Benzinga ChemoCentryx Shares Are Jumping 110% Thursday: Here's Why August 04, 2022 Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. Why Is It Moving? Via Benzinga Nasdaq Edges Higher; Crude Oil Falls Sharply August 04, 2022 U.S. stocks pared some losses midway through trading, with the Nasdaq Composite turning higher on Thursday. Via Benzinga Why Is Nikola (NKLA) Stock Up Today? August 04, 2022 Nikola (NKLA) stock is climbing higher on Thursday thanks to the release of its earnings report for Q2 2022 and other news. Via InvestorPlace ChemoCentryx (NASDAQ: CCXI) to be Acquired by Amgen (NASDAQ: AMGN) for $3.7 Billion in Cash August 04, 2022 ChemoCentryx, Inc. (NASDAQ: CCXI) is engaged as a biopharmaceutical company that is focused on the research, development and commercialization of Via Spotlight Growth ChemoCentryx Stock More Than Doubles On $4B Buyout August 04, 2022 Via Benzinga ChemoCentryx Posts Favorable PK, PD Results Of Oral PD-L1 Inhibitor In Cancer April 13, 2022 Via Benzinga Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session August 04, 2022 Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday. Via Benzinga ChemoCentryx (CCXI) Stock Soars 100% on Amgen Acquisition August 04, 2022 ChemoCentryx (CCXI) stock is rocketing higher on Thursday as investors react to news of an acquisition deal with Amgen (AMGN). Via InvestorPlace Amgen Plans $3.7 Billion ChemoCentryx Buyout, Tapping Into A New Market August 04, 2022 The company will pay $52 per share to buy ChemoCentryx, a rare disease-focused firm. Via Investor's Business Daily Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate August 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga CCXI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of ChemoCentryx, Inc. Is Fair to Shareholders August 04, 2022 From Halper Sadeh LLP Via Business Wire 12 Health Care Stocks Moving In Wednesday's After-Market Session July 20, 2022 Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares increased by 15.1% to $0.63 during Wednesday's after-market session. The company's market cap stands at $16.7 million. Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session July 14, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga Bear Market Rally Lifts HealthCare Stocks Off Bottom June 22, 2022 Clearly we are in a biotech bear market with both diagnostics and vaccine revenues stalled. If gene editing stocks cannot offer breakthrough clinical news then stick with large cap biopharma. Via Talk Markets Why ChemoCentryx Shares Are Popping Off May 06, 2022 ChemoCentryx Inc (NASDAQ: CCXI) shares are trading higher by 21.45% at $19.00 after the company reported first-quarter results. ChemoCentryx reported quarterly losses of 55 cents... Via Benzinga 92 Biggest Movers From Friday May 09, 2022 Gainers Sidus Space, Inc. (NASDAQ: SIDU) jumped 51.8% to settle at $2.99 on Friday after the company announced a a memorandum of understanding with Dhruva Space to expand its partnership to further the... Via Benzinga 55 Stocks Moving In Friday's Mid-Day Session May 06, 2022 Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company. Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 06, 2022 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday May 06, 2022 It's the final day of trading this week and it begins with a deep dive into the biggest pre-market stock movers for Friday! Via InvestorPlace 24 Stocks Moving in Friday's Pre-Market Session May 06, 2022 Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 35% to $3.47 in pre-market trading. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend... Via Benzinga ChemoCentryx: Q1 Earnings Insights May 05, 2022 ChemoCentryx (NASDAQ:CCXI) reported its Q1 earnings results on Thursday, May 5, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings ChemoCentryx missed estimated... Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session May 05, 2022 Gainers Via Benzinga ChemoCentryx's Earnings: A Preview May 04, 2022 ChemoCentryx (NASDAQ:CCXI) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that ChemoCentryx... Via Benzinga NASDAQ: CCXI Investor Notice: Update in Lawsuit Against ChemoCentryx, Inc. Announced April 26, 2022 San Diego, CA -- (SBWIRE) -- 04/26/2022 -- An update was announced in the lawsuit that is pending for certain investors in in shares of ChemoCentryx, Inc. (NASDAQ: CCXI) against ChemoCentryx, Inc.over... Via SBWire Bonds Are Screaming “Recession.” That’s Great News For One Top Sector. March 29, 2022 The 10-2 year treasury yield spread is close to zero. Here's what you should do about this warning sign of a coming recession. Via InvestorPlace CHEMOCENTRYX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ChemoCentryx, Inc. - CCXI March 18, 2022 From Kahn Swick & Foti, LLC Via Business Wire 10 Health Care Stocks Whale Activity In Today's Session March 18, 2022 This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... Via Benzinga ChemoCentryx's Return On Capital Employed Insights March 04, 2022 ChemoCentryx (NASDAQ:CCXI) brought in sales totaling $2.31 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 81.68%, resulting in a loss of... Via Benzinga 68 Biggest Movers From Yesterday March 03, 2022 Gainers ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday. Imperial Petroleum Inc. (NASDAQ: IMPP) shares jumped 39.2% to... Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
